Chaitanya Desai, MD
Nephrology · Peoria, ILNPI 1508090234
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $108,005 of the $132,352 with a category attached, or 81.6%. 6 manufacturers reported payments, led by Lilly USA, LLC at 48.9% of the total. Reporting peaked in 2024 at $90,761 and has fallen 60.3% since, to $36,062 in 2025. Among nephrology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $1025.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$65K
- Boehringer Ingelheim$62K
- Travere Therapeutics, Inc.$5K
- Dendreon Pharmaceuticals LLC$226
- Abbott$167
- E.r. Squibb & Sons, L.L.C.$33
What the payments were for
- Consulting fees$10,0208%
- Speaking & faculty fees$108,00582%
- Travel & lodging$11,3469%
- Food & beverage$2,9812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 61 | $64,711 |
| Boehringer Ingelheim | 51 | $62,334 |
| Travere Therapeutics, Inc. | 11 | $4,881 |
| Dendreon Pharmaceuticals LLC | 3 | $226 |
| Abbott | 1 | $167 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$106,438
- Filspari$1,156
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$167
- PROVENGE$115
How this compares
$132,352 in reported general payments places this provider in the 95th percentile of 524 nephrology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 45 | $100,811 |
| Sevelamer Carbonate | 39 | $6,961 |
| Hydralazine Hcl | 15 | $187 |
| Losartan Potassium | 11 | $141 |
| Prednisone | 24 | $128 |
| Lisinopril | 15 | $81 |
| Furosemide | 11 | $19 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Peoria
- Timothy PfledererPeoria$46K
- Myles WolfChicago$2.1M
- Mohammed AhmedBolingbrook$1.1M
- Anis RaufHinsdale$453K
- Juan LermaEvergreen Park$351K
- Stuart SpragueEvanston$337K
- Suneel UdaniHinsdale$336K
- Susan QuagginChicago$262K
- Nicole StankusChicago$235K
- Omaima DeganiGurnee$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.